Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 49 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 9670186

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  2. US 9669027

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  3. US 9670215

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  4. US 9669014

    Small molecule inhibitors of superoxide dismutase expression

    Northwestern University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  5. US 9662327

    Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer

    Agios Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  6. US 9663519

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 30, 2017 · Expires May 25, 2037

    granted
  7. US 9657012

    FAAH inhibitors

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  8. US 9657023

    Polymorph of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  9. US 9650391

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  10. US 9650381

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 16, 2017 · Expires May 11, 2037

    granted
  11. US 9644004

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted May 9, 2017 · Expires May 4, 2037

    granted
  12. US 9643967

    Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 9, 2017 · Expires May 4, 2037

    granted
  13. US 9642898

    Use of serine protease inhibitors in the treatment of neutropenia

    MED DISCOVERY S.A. · Granted May 9, 2017 · Expires May 4, 2037

    granted
  14. US 9636329

    Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors

    Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  15. US 9630914

    Multitarget FAAH and COX inhibitors and therapeutical uses thereof

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  16. US 9630956

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  17. US 9630932

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  18. US 9624268

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  19. US 9624170

    4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  20. US 9624229

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  21. US 9624228

    Inhibitors of ERK and methods of use

    Kura Oncology, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  22. US 9624238

    4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  23. US 9616047

    Inhibitors of beta-catenin in treatment of colorectal cancer

    Regents of the University of Minnesota · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  24. US 9611292

    Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted